A detailed history of Orion Investment CO transactions in Biogen Inc. stock. As of the latest transaction made, Orion Investment CO holds 32,555 shares of BIIB stock, worth $4.77 Million. This represents 2.45% of its overall portfolio holdings.

Number of Shares
32,555
Previous 32,643 0.27%
Holding current value
$4.77 Million
Previous $7.57 Billion 16.61%
% of portfolio
2.45%
Previous 3.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$189.07 - $236.8 $16,638 - $20,838
-88 Reduced 0.27%
32,555 $6.31 Billion
Q2 2024

Aug 14, 2024

BUY
$190.52 - $236.72 $6.22 Million - $7.73 Million
32,643 New
32,643 $7.57 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.1B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Orion Investment CO Portfolio

Follow Orion Investment CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orion Investment CO, based on Form 13F filings with the SEC.

News

Stay updated on Orion Investment CO with notifications on news.